Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study-Reference-Cited by-同舟云学术

Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study

Published:2022-09-15 Issue:3 Volume:30 Page:303-314
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:J Hepato Biliary Pancreat

Author:

Komatsu Shohei¹^ORCID,Ueshima Kazuomi²,Kido Masahiro¹,Kuramitsu Kaori¹,Tsugawa Daisuke¹,Yanagimoto Hiroaki¹,Toyama Hirochika¹,Ku Yonon³,Kudo Masatoshi²,Fukumoto Takumi¹

Affiliation:

1. Division of Hepato‐Biliary‐Pancreatic Surgery, Department of Surgery Kobe University Graduate School of Medicine Kobe Japan

2. Department of Gastroenterology and Hepatology Kindai University Faculty of Medicine Osaka Japan

3. Department of Surgery Konan Medical Center Kobe Japan

Publisher

Wiley

Subject

Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhbp.1236

Reference34 articles.

1. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases